Published in J Mol Med (Berl) on October 01, 2004
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83
High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res (2006) 2.56
Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol (2008) 1.84
Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res (2008) 1.58
Exploratory analysis of the copy number alterations in glioblastoma multiforme. PLoS One (2008) 1.17
MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci (2014) 1.16
In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Am J Pathol (2005) 1.10
Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Neuro Oncol (2013) 1.05
Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res (2009) 1.04
Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch (2008) 1.01
Biology, genetics and imaging of glial cell tumours. Br J Radiol (2011) 1.00
Design and application of oncolytic HSV vectors for glioblastoma therapy. Expert Rev Neurother (2009) 0.98
Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas. BMC Cancer (2009) 0.95
An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas. J Neurooncol (2011) 0.93
Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone. Cancer Res (2014) 0.93
Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors. Oncotarget (2015) 0.93
PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541. Neuro Oncol (2010) 0.92
miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Cell Mol Neurobiol (2015) 0.92
Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med (2015) 0.90
Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer (2013) 0.89
Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer (2008) 0.89
A complete compilation of matrix metalloproteinase expression in human malignant gliomas. World J Clin Oncol (2012) 0.89
Spinal cord tumours: advances in genetics and their implications for treatment. Nat Rev Neurol (2013) 0.88
Advanced MR imaging of gliomas: an update. Biomed Res Int (2013) 0.88
Wavelet-based identification of DNA focal genomic aberrations from single nucleotide polymorphism arrays. BMC Bioinformatics (2011) 0.85
Impaired Pten expression in human malignant peripheral nerve sheath tumours. PLoS One (2012) 0.84
Molecular neuropathology of gliomas. Int J Mol Sci (2009) 0.83
Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures. BMC Res Notes (2010) 0.83
Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas. J Exp Clin Cancer Res (2015) 0.82
Candidate genes for the progression of malignant gliomas identified by microarray analysis. Neurosurg Rev (2007) 0.82
Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme. Neurol Med Chir (Tokyo) (2013) 0.81
Combined analysis of genome-wide expression and copy number profiles to identify key altered genomic regions in cancer. BMC Genomics (2012) 0.81
Identification of novel SNPs in glioblastoma using targeted resequencing. PLoS One (2011) 0.81
High frequency of the X-chromosome inactivation in young female patients with high-grade glioma. Diagn Pathol (2013) 0.79
Genome-wide copy number analysis in pediatric glioblastoma multiforme. Am J Cancer Res (2014) 0.79
Evolving Molecular Genetics of Glioblastoma. Chin Med J (Engl) (2016) 0.79
Impaired TGF-β induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53. Am J Cancer Res (2015) 0.78
Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro Oncol (2013) 0.78
Identification of cancer-driver genes in focal genomic alterations from whole genome sequencing data. Sci Rep (2016) 0.77
Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation. Oncol Lett (2015) 0.77
Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma. Proteome Sci (2016) 0.76
Pediatric bilateral large concurrent thalamic glioblastoma: An unusual case report. J Pediatr Neurosci (2014) 0.75
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation. Oncotarget (2016) 0.75
Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors. BMC Res Notes (2014) 0.75
PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. Int J Mol Sci (2016) 0.75
High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors. J Neuropathol Exp Neurol (2006) 1.43
A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Acta Neuropathol (2011) 1.30
Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas. J Neuropathol Exp Neurol (2003) 0.80